The Bombay Burma

Which are the latest news on The Bombay Burma?

Why is The Bombay Burmah Trading Corporation Ltd falling/rising?

As of 27-Jul, The Bombay Burmah Trading Corporation Ltd's stock price is rising to 1,496.00, reflecting a 2.59% increase after a trend reversal and outperforming its sector. Despite a poor long-term growth of -23.33% over the past year, today's performance indicates a temporary rebound driven by increased investor participation.

As of 27-Jul, The Bombay Burmah Trading Corporation Ltd's stock price is rising, currently at 1,496.00, reflecting a change of 37.75 (2.59%) upward. This increase can be attributed to several factors. Firstly, the stock has shown a trend reversal, gaining after two consecutive days of decline. Additionally, it outperformed its sector by 1.83% today, indicating a positive shift in investor sentiment.<BR><BR>The stock reached an intraday high of Rs 1500.25, marking a 2.88% increase, which suggests strong buying interest at that level. Furthermore, there has been a notable rise in investor participation, with delivery volume increasing by 3.75% compared to the 5-day average, indicating that more investors are willing to hold the stock rather than trade it quickly.<BR><BR>Despite these positive movements, it is important to note that the stock has experienced poor long-term growth, with a return of -23.33% over the past year. However, the recent performance today suggests a temporary rebound, possibly driven by short-term trading dynamics rather than a fundamental change in the company's long-term outlook.

How big is The Bombay Burma?

As of 10th June, The Bombay Burmah Trading Corporation Ltd has a market capitalization of 10,707.00 Cr and reported net sales of 19,538.62 Cr and net profit of 1,242.67 Cr over the latest four quarters.

As of 10th June, <BR><BR>Market Cap: The Bombay Burmah Trading Corporation Ltd has a market capitalization of 10,707.00 Cr, classified as Small Cap.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 19,538.62 Cr, while the sum of Net Profit for the same period is 1,242.67 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period for the balance sheet is March 2025. Shareholder's Funds are valued at 5,631.75 Cr, and Total Assets amount to 12,686.88 Cr.

Who are in the management team of The Bombay Burma?

The management team of The Bombay Burma includes Nusli N Wadia (Chairman), Ness N Wadia (Managing Director), and several independent directors: Minnie Bodhanwala, Rajesh Batra, Y S P Thorat, Vinesh Kumar Jairath, and Chandra Iyengar, along with Murli Manohar Purohit as Company Secretary. They oversee the company's operations and strategic direction.

The management team of The Bombay Burma includes the following individuals:<BR><BR>1. **Nusli N Wadia** - Chairman (Non-Executive)<BR>2. **Ness N Wadia** - Managing Director<BR>3. **Minnie Bodhanwala** - Director<BR>4. **Rajesh Batra** - Independent Director<BR>5. **Y S P Thorat** - Independent Director<BR>6. **Vinesh Kumar Jairath** - Independent Director<BR>7. **Chandra Iyengar** - Independent Director<BR>8. **Murli Manohar Purohit** - Company Secretary & Compliance Officer<BR><BR>This team plays a crucial role in overseeing the company's operations and strategic direction.

Who are the peers of the The Bombay Burma?

The peers of The Bombay Burma include Zydus Wellness, CCL Products, Avanti Feeds, Honasa Consumer, Godrej Agrovet, Manorama Industries, Bajaj Consumer, and Jyothy Labs. The Bombay Burma has a good management risk rating and a 1-year return of -25.49%, higher than Godrej Agrovet's -29.40% but lower than Bajaj Consumer's 220.20%.

Peers: The peers of The Bombay Burma are Zydus Wellness, CCL Products, Avanti Feeds, Honasa Consumer, Godrej Agrovet, Manorama Indust., Bajaj Consumer, and Jyothy Labs.<BR><BR>Quality Snapshot: Excellent management risk is observed at CCL Products, Avanti Feeds, Honasa Consumer, Godrej Agrovet, Manorama Indust., Bajaj Consumer, and Jyothy Labs, while Good management risk is found at Zydus Wellness and The Bombay Burma. Average management risk is noted for Zydus Wellness, The Bombay Burma, and Honasa Consumer. Growth is classified as Excellent for Manorama Indust., Good for Honasa Consumer, and Average for CCL Products, while Below Average growth is seen in Zydus Wellness, Avanti Feeds, Godrej Agrovet, The Bombay Burma, and Bajaj Consumer. Capital Structure is Excellent for Zydus Wellness, Avanti Feeds, The Bombay Burma, Bajaj Consumer, and Jyothy Labs, while Average capital structure is found at CCL Products and Godrej Agrovet.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Bajaj Consumer at 220.20%, while the lowest is Godrej Agrovet at -29.40%. The 1-year return for The Bombay Burma is -25.49%, which is higher than Godrej Agrovet's return but lower than Bajaj Consumer's. Additionally, the six-month return is negative for The Bombay Burma, Godrej Agrovet, and Jyothy Labs.

What does The Bombay Burma do?

The Bombay Burmah Trading Corporation Ltd is a multi-product FMCG company involved in plantations, auto electric components, healthcare, and real estate. As of March 2026, it reported net sales of ₹4,818 Cr and a net profit of ₹444 Cr, with a market cap of ₹10,707 Cr.

Overview:<BR>The Bombay Burmah Trading Corporation Ltd is a multi-product organization engaged in the FMCG sector, focusing on plantations, auto electric components, healthcare, and real estate.<BR><BR>History:<BR>The company was incorporated in the 19th century and has evolved over the years with diverse business interests. The latest quarterly results reported net sales and net profit for the period ending March 2026.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 4,818 Cr (Quarterly Results - Mar 2026) <BR>Most recent Net Profit: 444 Cr (Quarterly Results - Mar 2026) <BR>Market-cap value: INR 10,707 Cr (Small Cap)<BR><BR>Key Metrics:<BR>P/E: 9.00 <BR>Industry P/E: 45 <BR>Dividend Yield: 1.11% <BR>Debt-Equity: -0.13 <BR>Return on Equity: 16.49% <BR>Price to Book: 1.52 <BR><BR>Contact Details:<BR>Address: 9 Wallace Street, Fort Mumbai Maharashtra : 400001 <BR>Phone: 91-22-22197101 <BR>Email: bbtcl@bom2.vsnl.net.in / investorser <BR>Website: http://www.bbtcl.com

Are The Bombay Burmah Trading Corporation Ltd latest results good or bad?

The latest results for The Bombay Burmah Trading Corporation Ltd show a strong profit increase of 43.84% year-on-year, but a revenue decline of 4.89% from the previous quarter and slight margin compression raise concerns about sustainability, leading to a cautious market sentiment and a "SELL" rating.

The latest results for The Bombay Burmah Trading Corporation Ltd present a mixed picture. On one hand, the company reported a consolidated net profit of ₹443.96 crores for Q4 FY26, which is a significant increase of 43.84% year-on-year and a 40.35% rise from the previous quarter. This indicates strong operational performance and improved efficiency.<BR><BR>However, the quarterly revenue of ₹4,817.99 crores reflects a decline of 4.89% compared to the previous quarter, although it shows a year-on-year growth of 6.62%. The operating margin has also compressed slightly to 17.4%, down from 17.98% a year ago, indicating some pressure on profitability due to rising costs and competitive challenges in the FMCG sector.<BR><BR>Overall, while the profit growth is encouraging, the decline in revenue and margin compression raises concerns about the sustainability of this performance. The market sentiment appears cautious, reflected in a "SELL" rating and an overall score of 35 out of 100, suggesting that investors should be wary of potential challenges ahead.

Should I buy, sell or hold The Bombay Burmah Trading Corporation Ltd?

When is the next results date for The Bombay Burmah Trading Corporation Ltd?

The next results date for The Bombay Burmah Trading Corporation Ltd is 13 February 2026.

The next results date for The Bombay Burmah Trading Corporation Ltd is scheduled for 13 February 2026.

How has been the historical performance of Bombay Burmah?

Bombay Burmah has shown steady growth in net sales and operating income from Mar'19 to Mar'25, with operating profit and profit before tax significantly improving. After a loss in Mar'23, profit after tax rebounded to 2,050.54 Cr in Mar'25, reflecting a recovery in financial health and operational efficiency.

Answer:<BR>The historical performance of Bombay Burmah shows a steady increase in net sales, rising from 11,423.20 Cr in Mar'19 to 18,298.01 Cr in Mar'25. Total operating income has similarly grown, reaching 18,298.01 Cr in Mar'25 from 11,423.20 Cr in Mar'19. The total expenditure has also increased, but at a slower rate, from 9,740.65 Cr in Mar'19 to 15,162.41 Cr in Mar'25. Operating profit, excluding other income, has shown a positive trend, increasing from 1,682.55 Cr in Mar'19 to 3,135.60 Cr in Mar'25, although it peaked at 3,497.70 Cr in Mar'24. Profit before tax has also improved significantly, from 1,674.85 Cr in Mar'19 to 2,907.90 Cr in Mar'25, while profit after tax has rebounded from a loss of 1,675.73 Cr in Mar'23 to a profit of 2,050.54 Cr in Mar'25. The earnings per share (EPS) reflect this recovery, moving from -240.08 in Mar'23 to 160.95 in Mar'25. The company's total assets have decreased from 15,676.75 Cr in Mar'23 to 12,686.88 Cr in Mar'25, while total liabilities have also decreased from 15,676.75 Cr in Mar'23 to 12,686.88 Cr in Mar'25. Cash flow from operating activities has improved, reaching 2,277.00 Cr in Mar'25, compared to 1,409.00 Cr in Mar'20.<BR><BR>Breakdown:<BR>Bombay Burmah's financial performance over the years indicates a robust growth trajectory in net sales, which increased consistently from 11,423.20 Cr in Mar'19 to 18,298.01 Cr in Mar'25. This growth in sales has been accompanied by a rise in total operating income, which reached the same figure as net sales by Mar'25. While total expenditure has risen, the operating profit has shown a commendable increase, particularly from Mar'21 to Mar'25, highlighting the company's ability to manage costs effectively. The profit before tax has also seen a significant rise, reflecting improved operational efficiency and profitability. After experiencing a substantial loss in Mar'23, the profit after tax rebounded strongly in Mar'25, demonstrating a recovery in the company's financial health. The earnings per share have mirrored this recovery, showcasing a positive shift from negative to strong positive values. Despite a decrease in total assets and liabilities from their peak in Mar'23, the company has maintained a healthy cash flow from operating activities, indicating solid operational performance. Overall, the data reflects a company on a path of recovery and growth, with improved profitability and operational efficiency.

Is Bombay Burmah technically bullish or bearish?

As of November 3, 2025, the market trend is mildly bearish, indicated by daily moving averages and weekly Dow Theory, despite mixed signals from the MACD and RSI suggesting a cautious outlook.

As of 3 November 2025, the technical trend has changed from sideways to mildly bearish. The current technical stance is mildly bearish, driven by the daily moving averages indicating a bearish outlook and the weekly Dow Theory also reflecting a mildly bearish sentiment. The MACD shows a bullish signal on the weekly but is mildly bearish on the monthly, while the RSI is bullish on the monthly but shows no signal on the weekly. Overall, the mixed signals from the indicators suggest a cautious bearish outlook, with the strength of the bearish trend being mild.

Is Bombay Burmah overvalued or undervalued?

As of February 13, 2024, Bombay Burmah's valuation has shifted to very expensive, indicating it is overvalued at a price of 2014.35, despite a lower PE ratio compared to peers like Hindustan Unilever and Nestle India, and a strong ROCE of 50.63%.

As of 13 February 2024, the valuation grade for Bombay Burmah has moved from very attractive to very expensive, indicating a significant shift in its market perception. The company is currently deemed overvalued based on its financial metrics. Key ratios include a PE Ratio of 12.26, an EV to EBITDA of 4.40, and a ROE of 20.11%. <BR><BR>When compared to its peers, Bombay Burmah's valuation stands out as it has a much lower PE ratio compared to Hindustan Unilever at 53.88 and Nestle India at 75.2, both of which are also classified as very expensive. Despite a strong ROCE of 50.63%, the overall valuation suggests that the stock may not justify its current price of 2014.35, especially given its recent performance against the Sensex, where it has underperformed in the year-to-date period.

Who are the top shareholders of the Bombay Burmah?

The top shareholders of Bombay Burmah include Nowrosjee Wadia & Sons Limited with 38.97%, 171 foreign institutional investors owning 9.6%, and Acacia Institutional Partners, Lp as the largest public shareholder at 1.5%. Individual investors hold 11.66% of the shares, while mutual funds have a combined stake of 0.37%.

The top shareholders of Bombay Burmah include the promoters, with Nowrosjee Wadia & Sons Limited holding the largest stake at 38.97%. Additionally, the company has 171 foreign institutional investors (FIIs) collectively owning 9.6% of the shares. Mutual funds are represented by 13 schemes, which hold 0.37%. The highest public shareholder is Acacia Institutional Partners, Lp, with a stake of 1.5%. Individual investors also hold a significant portion, accounting for 11.66% of the shares.

Has Bombay Burmah declared dividend?

Bombay Burmah Trading Corporation Ltd has declared a 200% dividend, amounting to ₹4 per share, with an ex-date of March 27, 2025. The company has shown varying total returns over different periods, with a total return of 31.12% over the past year.

Bombay Burmah Trading Corporation Ltd has declared a 200% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 200%<BR>- Amount per share: 4<BR>- Ex-date: 27 Mar 25<BR><BR>Dividend Yield: 0.92%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -15.85%, the dividend return was 0.72%, resulting in a total return of -15.13%.<BR><BR>Over the past year, the price return was 30.01%, the dividend return was 1.11%, leading to a total return of 31.12%.<BR><BR>In the last 2 years, the price return was 110.67%, the dividend return was 1.85%, culminating in a total return of 112.52%.<BR><BR>For the 3-year period, the price return stood at 99.38%, the dividend return at 2.31%, resulting in a total return of 101.69%.<BR><BR>In the 4-year span, the price return was 54.34%, the dividend return was 1.59%, giving a total return of 55.93%.<BR><BR>Finally, over the last 5 years, the price return was 81.02%, the dividend return was 2.23%, leading to a total return of 83.25%.<BR><BR>Overall, Bombay Burmah has shown a significant dividend declaration alongside varying total returns across different periods, indicating a mix of performance in terms of price appreciation and dividend income.